000952 广济药业
已收盘 11-06 15:00:00
资讯
新帖
简况
广济药业：截至2026年10月30日，公司股东总户数26,857户
证券之星 · 11-03
广济药业：截至2026年10月30日，公司股东总户数26,857户
广济药业（000952）2026年三季报简析：营收上升亏损收窄
证券之星 · 10-31
广济药业（000952）2026年三季报简析：营收上升亏损收窄
广济药业(000952)10月20日股东户数2.7万户，较上期增加0.18%
证券之星 · 10-30
广济药业(000952)10月20日股东户数2.7万户，较上期增加0.18%
股市必读：广济药业新发布《2026年三季度报告》
证券之星 · 10-30
股市必读：广济药业新发布《2026年三季度报告》
图解广济药业三季报：第三季度单季净利润同比增长91.00%
证券之星 · 10-30
图解广济药业三季报：第三季度单季净利润同比增长91.00%
广济药业（000952）10月19日主力资金净买入232.53万元
证券之星 · 10-19
广济药业（000952）10月19日主力资金净买入232.53万元
广济药业：截至2026年9月30日，公司股东总户数26,970户
证券之星 · 10-14
广济药业：截至2026年9月30日，公司股东总户数26,970户
股市必读：广济药业新发布《湖北广济药业股份有限公司及申港证券股份有限公司关于湖北广济药业股份有限公司申请向特定对象发行股票的审核问询函之回复》
证券之星 · 10-08
股市必读：广济药业新发布《湖北广济药业股份有限公司及申港证券股份有限公司关于湖北广济药业股份有限公司申请向特定对象发行股票的审核问询函之回复》
广济药业（000952）披露2026年度向特定对象发行A股股票募集说明书（修订稿），9月30日股价下跌0.45%
证券之星 · 09-30
广济药业（000952）披露2026年度向特定对象发行A股股票募集说明书（修订稿），9月30日股价下跌0.45%
股市必读：广济药业新发布《湖北广济药业股份有限公司及申港证券股份有限公司关于湖北广济药业股份有限公司申请向特定对象发行股票的审核问询函之回复》
证券之星 · 09-30
股市必读：广济药业新发布《湖北广济药业股份有限公司及申港证券股份有限公司关于湖北广济药业股份有限公司申请向特定对象发行股票的审核问询函之回复》
广济药业（000952）9月28日主力资金净买入103.69万元
证券之星 · 09-28
广济药业（000952）9月28日主力资金净买入103.69万元
9月21日保利发展涨6.77%，招商沪深300地产等权重指数A基金重仓该股
证券之星 · 09-21
9月21日保利发展涨6.77%，招商沪深300地产等权重指数A基金重仓该股
9月18日保利发展涨5.56%，招商沪深300地产等权重指数A基金重仓该股
证券之星 · 09-18
9月18日保利发展涨5.56%，招商沪深300地产等权重指数A基金重仓该股
股市必读：广济药业（000952）9月16日董秘有最新回复
证券之星 · 09-17
股市必读：广济药业（000952）9月16日董秘有最新回复
广济药业：截至2026年9月10日，公司股东总户数26,968户
证券之星 · 09-16
广济药业：截至2026年9月10日，公司股东总户数26,968户
广济药业最新公告：拟公开挂牌转让长投安华酒店49%股权
证券之星 · 09-15
广济药业最新公告：拟公开挂牌转让长投安华酒店49%股权
广济药业：截至2026年8月31日，公司股东总户数27,041户
证券之星 · 09-03
广济药业：截至2026年8月31日，公司股东总户数27,041户
广济药业（000952）2026年中报简析：营收上升亏损收窄
证券之星 · 08-29
广济药业（000952）2026年中报简析：营收上升亏损收窄
图解广济药业中报：第二季度单季净利润同比增长32.99%
证券之星 · 08-27
图解广济药业中报：第二季度单季净利润同比增长32.99%
广济药业(000952)8月20日股东户数2.74万户，较上期减少0.96%
证券之星 · 08-27
广济药业(000952)8月20日股东户数2.74万户，较上期减少0.96%
加载更多
公司概况
公司名称：
湖北广济药业股份有限公司
所属行业：
医药制造业
上市日期：
1999-11-12
主营业务：
湖北广济药业股份有限公司的主营业务是维生素原料产品的研发、生产和销售。公司的主要产品是维生素B2、B6、医药制剂。公司曾获得“全国维生素产业十强企业”“全国饲料添加剂科技创新优秀企业”等多项荣誉称号。
发行价格：
5.03
{"stockData":{"symbol":"000952","market":"SZ","secType":"STK","nameCN":"广济药业","latestPrice":5.67,"timestamp":1793948607000,"preClose":5.75,"halted":0,"volume":6379500,"delay":0,"changeRate":-0.0139,"floatShares":344000000,"shares":344000000,"eps":-1.0672,"marketStatus":"已收盘","change":-0.08,"latestTime":"11-06 15:00:00","open":5.65,"high":5.74,"low":5.54,"amount":36050100,"amplitude":0.0348,"askPrice":5.68,"askSize":22,"bidPrice":5.67,"bidSize":3,"shortable":0,"etf":0,"ttmEps":-1.0672,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1794187800000},"marketStatusCode":5,"adr":0,"adjPreClose":5.75,"symbolType":"stock","openAndCloseTimeList":[[1793928600000,1793935800000],[1793941200000,1793948400000]],"highLimit":6.33,"lowLimit":5.18,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":343999939,"isCdr":false,"pbRate":3.32,"roa":"--","roe":"--","epsLYR":-1.1613,"committee":0.671716,"marketValue":1950000000,"turnoverRate":0.0185,"status":1,"floatMarketCap":1950000000},"requestUrl":"/m/hq/s/000952/","defaultTab":"news","newsList":[{"id":"2680729184","title":"广济药业：截至2026年10月30日，公司股东总户数26,857户","url":"https://stock-news.laohu8.com/highlight/detail?id=2680729184","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680729184?lang=zh_cn&edition=full","pubTime":"2026-11-03 20:51","pubTimestamp":1793710295,"startTime":"0","endTime":"0","summary":"证券之星消息，广济药业(000952)11月02日在投资者关系平台上答复投资者关心的问题。投资者提问：请问公司最新一期的股东户数是多少？谢谢广济药业回复：您好，截至2026年10月30日，公司股东总户数26,857户。感谢您对公司的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110300040838.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","000952","BK0191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679222569","title":"广济药业（000952）2026年三季报简析：营收上升亏损收窄","url":"https://stock-news.laohu8.com/highlight/detail?id=2679222569","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679222569?lang=zh_cn&edition=full","pubTime":"2026-10-31 11:42","pubTimestamp":1793418162,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期广济药业发布2026年三季报。根据财报显示，广济药业营收上升亏损收窄。截至本报告期末，公司营业总收入4.35亿元，同比上升1.44%，归母净利润-5990.59万元，同比上升38.43%。本次财报公布的各项数据指标表现尚佳。财报体检工具显示：建议关注公司现金流状况建议关注公司债务状况建议关注财务费用状况建议关注公司应收账款状况本文数据来源于广济药业2026年三季报，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103100024940.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000952"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679721356","title":"广济药业(000952)10月20日股东户数2.7万户，较上期增加0.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679721356","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679721356?lang=zh_cn&edition=full","pubTime":"2026-10-30 19:18","pubTimestamp":1793359103,"startTime":"0","endTime":"0","summary":"证券之星消息，近日广济药业披露，截至2026年10月20日公司股东户数为2.7万户，较9月30日增加49.0户，增幅为0.18%。在化学制药行业个股中，广济药业股东户数低于行业平均水平，截至10月20日，化学制药行业平均股东户数为3.98万户。从股价来看，2026年9月30日至2026年10月20日，广济药业区间跌幅为5.63%，在此期间股东户数增加49.0户，增幅为0.18%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103000047273.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","000952","BK0191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679586762","title":"股市必读：广济药业新发布《2026年三季度报告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2679586762","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679586762?lang=zh_cn&edition=full","pubTime":"2026-10-30 07:06","pubTimestamp":1793315212,"startTime":"0","endTime":"0","summary":"截至2026年10月29日收盘，广济药业报收于5.75元，下跌2.38%，换手率1.2%，成交量4.13万手，成交额2403.73万元。公司公告汇总：2026年三季度报告披露，本报告期归母净利润为-196.08万元，同比增长91.00%；年初至报告期末归母净利润为-5990.59万元，同比增长38.43%；经营活动现金流净额1.14亿元，同比增长138.25%。公司公告汇总2026年三季度报告湖北广济药业股份有限公司2026年第三季度报告显示，本报告期营业收入123,491,181.22元，同比下降14.78%；归属于上市公司股东的净利润-1,960,754.81元，同比增长91.00%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103000013190.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000952","BK0191","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679232663","title":"图解广济药业三季报：第三季度单季净利润同比增长91.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679232663","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679232663?lang=zh_cn&edition=full","pubTime":"2026-10-30 05:23","pubTimestamp":1793309003,"startTime":"0","endTime":"0","summary":"证券之星消息，广济药业2026年三季报显示，前三季度公司主营收入4.35亿元，同比上升1.44%；归母净利润-5990.59万元，同比上升38.43%；扣非净利润-8709.27万元，同比上升14.17%；其中2026年第三季度，公司单季度主营收入1.23亿元，同比下降14.78%；单季度归母净利润-196.08万元，同比上升91.0%；单季度扣非净利润-2150.4万元，同比上升6.74%；负债率72.89%，投资收益-78.13万元，财务费用3509.17万元，毛利率27.25%。财报数据概要请见下图:本文数据来源于广济药业2026年三季报，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103000006566.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000952"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676505445","title":"广济药业（000952）10月19日主力资金净买入232.53万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2676505445","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676505445?lang=zh_cn&edition=full","pubTime":"2026-10-19 15:33","pubTimestamp":1792395206,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月19日收盘，广济药业报收于6.25元，下跌2.95%，换手率2.55%，成交量8.77万手，成交额5500.51万元。广济药业主营业务：专业从事维生素原料及医药制剂研发、生产和销售的高新技术企业,是全球主要的维生素B2产品供应商之一。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101900013520.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0191","000952","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675342317","title":"广济药业：截至2026年9月30日，公司股东总户数26,970户","url":"https://stock-news.laohu8.com/highlight/detail?id=2675342317","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675342317?lang=zh_cn&edition=full","pubTime":"2026-10-14 20:52","pubTimestamp":1791982332,"startTime":"0","endTime":"0","summary":"证券之星消息，广济药业(000952)10月13日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬的董秘您好，请问公司九月底的股东人数，谢谢广济药业回复：您好，截至2026年9月30日，公司股东总户数26,970户。感谢您对公司的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101400037756.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000952","BK0191","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673017616","title":"股市必读：广济药业新发布《湖北广济药业股份有限公司及申港证券股份有限公司关于湖北广济药业股份有限公司申请向特定对象发行股票的审核问询函之回复》","url":"https://stock-news.laohu8.com/highlight/detail?id=2673017616","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673017616?lang=zh_cn&edition=full","pubTime":"2026-10-08 03:00","pubTimestamp":1791399637,"startTime":"0","endTime":"0","summary":"湖北广济药业股份有限公司及申港证券股份有限公司关于湖北广济药业股份有限公司申请向特定对象发行股票的审核问询函之回复公司说明2023年至2025年营业收入持续下滑、扣非归母净利润连续亏损，主因部分子公司资产减值及生产线停工；截至2026年3月末，财务性投资合计728万元，占归母净资产比例为1.17%；本次发行由长江产业集团全额认购，资金来源为其自有资金。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100800001477.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0191","BK0239","161027","000952"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671270435","title":"广济药业（000952）披露2026年度向特定对象发行A股股票募集说明书（修订稿），9月30日股价下跌0.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2671270435","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671270435?lang=zh_cn&edition=full","pubTime":"2026-09-30 17:35","pubTimestamp":1790760954,"startTime":"0","endTime":"0","summary":"截至2026年9月30日收盘，广济药业报收于6.57元，较前一交易日下跌0.45%，最新总市值为22.6亿元。近日，广济药业披露《2026年度向特定对象发行A股股票募集说明书（修订稿）》。公告显示，公司拟向控股股东长江产业集团定向发行A股股票，募集资金总额不超过60,000万元，用于偿还借款和补充流动资金。发行完成后，长江产业集团持股比例将升至41.58%。本次发行尚需深交所审核通过及中国证监会注册。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026093000028163.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["02822","82823","02846","399300","07233","83188","02843","159982","BK1610","03130","000952","BK0239","03188","BK1147","BK0191","82843","82846","82822","83130","02823","02827"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671244738","title":"股市必读：广济药业新发布《湖北广济药业股份有限公司及申港证券股份有限公司关于湖北广济药业股份有限公司申请向特定对象发行股票的审核问询函之回复》","url":"https://stock-news.laohu8.com/highlight/detail?id=2671244738","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671244738?lang=zh_cn&edition=full","pubTime":"2026-09-30 03:15","pubTimestamp":1790709315,"startTime":"0","endTime":"0","summary":"公司公告汇总申港证券股份有限公司关于湖北广济药业股份有限公司向特定对象发行股票之上市保荐书（修订稿）申港证券作为保荐机构，对广济药业向特定对象发行股票事项出具上市保荐书。利安达会计师事务所关于湖北广济药业股份有限公司申请向特定对象发行股票的审核问询函的回复广济药业就申请向特定对象发行股票事项回复深圳证券交易所审核问询函。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026093000002971.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0191","BK0239","161027","000952"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670282857","title":"广济药业（000952）9月28日主力资金净买入103.69万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2670282857","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670282857?lang=zh_cn&edition=full","pubTime":"2026-09-28 15:31","pubTimestamp":1790580688,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年9月28日收盘，广济药业报收于6.55元，上涨1.08%，换手率2.0%，成交量6.87万手，成交额4484.74万元。9月28日的资金流向数据方面，主力资金净流入103.69万元，占总成交额2.31%，游资资金净流入239.98万元，占总成交额5.35%，散户资金净流出343.67万元，占总成交额7.66%。广济药业主营业务：主要从事维生素B2、B6原料系列产品以及医药制剂产品的研发、生产和销售等业务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092800014724.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0191","000952","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669328159","title":"9月21日保利发展涨6.77%，招商沪深300地产等权重指数A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2669328159","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669328159?lang=zh_cn&edition=full","pubTime":"2026-09-21 16:37","pubTimestamp":1789979844,"startTime":"0","endTime":"0","summary":"证券之星消息，9月21日保利发展涨6.77%创60日新高，收盘报5.68元，换手率4.04%，成交量483.4万手，成交额26.69亿元。根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共38家，其中持有数量最多的公募基金为招商基金的招商沪深300地产等权重指数A。招商沪深300地产等权重指数A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092100020762.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0010","BK0239","LU1794554557.SGD","600048","BK0188","BK0189","BK0196","BK0273","LU1720050803.USD","BK0191","BK0012","000952","BK0082","BK0183","LU1997245177.USD","LU1997245094.SGD","BK0028","BK0187","BK0015"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668394918","title":"9月18日保利发展涨5.56%，招商沪深300地产等权重指数A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2668394918","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668394918?lang=zh_cn&edition=full","pubTime":"2026-09-18 16:37","pubTimestamp":1789720671,"startTime":"0","endTime":"0","summary":"证券之星消息，9月18日保利发展涨5.56%，收盘报5.32元，换手率2.47%，成交量295.73万手，成交额15.42亿元。根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共38家，其中持有数量最多的公募基金为招商基金的招商沪深300地产等权重指数A。招商沪深300地产等权重指数A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091800025722.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0183","LU1720050803.USD","LU1997245094.SGD","BK0187","LU1997245177.USD","BK0188","LU1794554557.SGD","BK0191","BK0012","BK0196","BK0273","BK0189","BK0028","BK0082","BK0239","600048","BK0010","000952","BK0015"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668908987","title":"股市必读：广济药业（000952）9月16日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2668908987","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668908987?lang=zh_cn&edition=full","pubTime":"2026-09-17 01:09","pubTimestamp":1789578554,"startTime":"0","endTime":"0","summary":"截至2026年9月16日收盘，广济药业报收于6.26元，上涨0.64%，换手率1.29%，成交量4.42万手，成交额2761.44万元。董秘最新回复投资者： 您好，请问一下9月10号的股东人数是多少？谢谢董秘： 您好，截至2026年9月10日，公司股东总户数26,968户。当日关注点交易信息汇总：9月16日主力资金净流出2.6万元，占总成交额0.09%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091700000631.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0191","000952","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667985697","title":"广济药业：截至2026年9月10日，公司股东总户数26,968户","url":"https://stock-news.laohu8.com/highlight/detail?id=2667985697","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667985697?lang=zh_cn&edition=full","pubTime":"2026-09-16 20:48","pubTimestamp":1789562906,"startTime":"0","endTime":"0","summary":"证券之星消息，广济药业(000952)09月16日在投资者关系平台上答复投资者关心的问题。投资者提问：您好，请问一下9月10号的股东人数是多少？谢谢广济药业回复：您好，截至2026年9月10日，公司股东总户数26,968户。感谢您对公司的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091600035201.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0191","000952"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667664146","title":"广济药业最新公告：拟公开挂牌转让长投安华酒店49%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2667664146","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667664146?lang=zh_cn&edition=full","pubTime":"2026-09-15 19:19","pubTimestamp":1789471179,"startTime":"0","endTime":"0","summary":"广济药业(000952.SZ)公告称，公司拟在武汉光谷联合产权交易所公开挂牌转让所持有的湖北长投安华酒店有限公司（简称“长投安华酒店”）49%股权。公司本次挂牌转让价格将不低于经备案的对应股权评估价值2213.78万元。本次交易完成后，公司不再持有长投安华酒店的股份。公司控股股东长江产业集团有限公司全资子公司湖北长江产业资产经营管理有限公司拟参与竞拍。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091500032382.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","000952","BK0191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664872680","title":"广济药业：截至2026年8月31日，公司股东总户数27,041户","url":"https://stock-news.laohu8.com/highlight/detail?id=2664872680","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664872680?lang=zh_cn&edition=full","pubTime":"2026-09-03 20:51","pubTimestamp":1788439873,"startTime":"0","endTime":"0","summary":"证券之星消息，广济药业(000952)09月02日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止2026年8月31日，公司股东人数多少？广济药业回复：您好，截至2026年8月31日，公司股东总户数27,041户。感谢您对公司的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090300039796.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","000952","BK0191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663016953","title":"广济药业（000952）2026年中报简析：营收上升亏损收窄","url":"https://stock-news.laohu8.com/highlight/detail?id=2663016953","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663016953?lang=zh_cn&edition=full","pubTime":"2026-08-29 06:22","pubTimestamp":1787955764,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期广济药业发布2026年中报。根据财报显示，广济药业营收上升亏损收窄。截至本报告期末，公司营业总收入3.12亿元，同比上升9.71%，归母净利润-5794.51万元，同比上升23.27%。按单季度数据看，第二季度营业总收入1.49亿元，同比上升9.56%，第二季度归母净利润-2630.15万元，同比上升32.99%。本次财报公布的各项数据指标表现尚佳。本文数据来源于广济药业2026年中报，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082900011130.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000952"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662709715","title":"图解广济药业中报：第二季度单季净利润同比增长32.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662709715","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662709715?lang=zh_cn&edition=full","pubTime":"2026-08-27 18:59","pubTimestamp":1787828368,"startTime":"0","endTime":"0","summary":"证券之星消息，广济药业2026年中报显示，上半年度公司主营收入3.12亿元，同比上升9.71%；归母净利润-5794.51万元，同比上升23.27%；扣非净利润-6558.87万元，同比上升16.35%；其中2026年第二季度，公司单季度主营收入1.49亿元，同比上升9.56%；单季度归母净利润-2630.15万元，同比上升32.99%；单季度扣非净利润-3290.39万元，同比上升20.06%；负债率74.01%，投资收益-66.84万元，财务费用2446.77万元，毛利率23.25%。财报数据概要请见下图:本文数据来源于广济药业2026年中报，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700045149.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000952"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662033577","title":"广济药业(000952)8月20日股东户数2.74万户，较上期减少0.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662033577","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662033577?lang=zh_cn&edition=full","pubTime":"2026-08-27 18:05","pubTimestamp":1787825103,"startTime":"0","endTime":"0","summary":"证券之星消息，近日广济药业披露，截至2026年8月20日公司股东户数为2.74万户，较8月10日减少266.0户，减幅为0.96%。在化学制药行业个股中，广济药业股东户数低于行业平均水平，截至8月20日，化学制药行业平均股东户数为3.67万户。从股价来看，2026年8月10日至2026年8月20日，广济药业区间涨幅为5.98%，在此期间股东户数减少266.0户，减幅为0.96%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700043024.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000952","BK0191","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1793970718585,"stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":-0.1248},{"period":"3month","weight":-0.0496},{"period":"6month","weight":-0.2424},{"period":"1year","weight":-0.2166},{"period":"ytd","weight":-0.1821}],"compareEarnings":[{"period":"1week","weight":0.0105},{"period":"1month","weight":-0.0396},{"period":"3month","weight":-0.0635},{"period":"6month","weight":-0.1172},{"period":"1year","weight":-0.0704},{"period":"ytd","weight":-0.0703}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"湖北广济药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"26857人(较上一季度减少0.60%)","perCapita":"12808股","listingDate":"1999-11-12","address":"湖北省黄冈市武穴市大金镇梅武路100号","registeredCapital":"34399万元","survey":" 湖北广济药业股份有限公司的主营业务是维生素原料产品的研发、生产和销售。公司的主要产品是维生素B2、B6、医药制剂。公司曾获得“全国维生素产业十强企业”“全国饲料添加剂科技创新优秀企业”等多项荣誉称号。","listedPrice":5.03},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"广济药业(000952)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供广济药业(000952)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"广济药业,000952,广济药业股票,广济药业股票老虎,广济药业股票老虎国际,广济药业行情,广济药业股票行情,广济药业股价,广济药业股市,广济药业股票价格,广济药业股票交易,广济药业股票购买,广济药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"广济药业(000952)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供广济药业(000952)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}